{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:04:06Z","timestamp":1780517046133,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["EQU202103012670"],"award-info":[{"award-number":["EQU202103012670"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.imlet.2026.107178","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:50:30Z","timestamp":1776243030000},"page":"107178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["1995\u20132025: A long journey in the ALPS"],"prefix":"10.1016","volume":"280","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Rieux-Laucat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2026.107178_bib0001","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.imlet.2026.107178_bib0002","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2026.107178_bib0003","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defect in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2026.107178_bib0004","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0092-8674(91)90614-5","article-title":"The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis","volume":"66","author":"Itoh","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2026.107178_bib0005","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1016\/S0021-9258(19)50076-X","article-title":"Purification and molecular cloning of the APO-1 cell surface antigen, a member of the Tumor Necrosis Factor\/Nerve Growth Factor Receptor superfamily","volume":"267","author":"Oehm","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2026.107178_bib0006","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.imlet.2026.107178_bib0007","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/eji.1830270831","article-title":"Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation","volume":"27","author":"Benkerrou","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2026.107178_bib0008","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V89.3.902","article-title":"Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis","volume":"89","author":"Bettinardi","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2026.107178_bib0009","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bj.2021.06.005","article-title":"The genetic landscape of the FAS pathway deficiencies","volume":"44","author":"Magerus","year":"2021","journal-title":"Biomed. J."},{"key":"10.1016\/j.imlet.2026.107178_bib0010","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMoa040036","article-title":"Autoimmune lymphoproliferative syndrome with somatic Fas mutations","volume":"351","author":"Holzelova","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2026.107178_bib0011","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI43752","article-title":"Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation","volume":"121","author":"Magerus-Chatinet","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.imlet.2026.107178_bib0012","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/blood-2008-09-179630","article-title":"FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha\/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function","volume":"113","author":"Magerus-Chatinet","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2026.107178_bib0013","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","article-title":"Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family","volume":"75","author":"Suda","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2026.107178_bib0014","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","article-title":"Generalized lymphoproliferative disease in mice, caused by a point mutation in the FAS ligand","volume":"76","author":"Takahashi","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2026.107178_bib0015","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","article-title":"Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease","volume":"98","author":"Wu","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.imlet.2026.107178_bib0016","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2006-04-015776","article-title":"A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome","volume":"108","author":"Del-Rey","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2026.107178_bib0017","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2012.06.011","article-title":"Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation","volume":"131","author":"Magerus-Chatinet","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2026.107178_bib0018","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jaci.2022.11.028","article-title":"Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations","volume":"151","author":"Maccari","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2026.107178_bib0019","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/cdd.2011.155","article-title":"Regulation of CD95\/Fas signaling at the DISC","volume":"19","author":"Lavrik","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.imlet.2026.107178_bib0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0092-8674(95)90071-3","article-title":"FADD, a novel death domain-containing protein, interacts with the death domains of fas and initiates apoptosis","volume":"81","author":"Chinnaiyan","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2026.107178_bib0021","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","article-title":"Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor","volume":"14","author":"Kischkel","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.imlet.2026.107178_bib0022","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80549-X","article-title":"A role for FADD in T cell activation and development","volume":"8","author":"Walsh","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2026.107178_bib0023","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.111158698","article-title":"T cell-specific FADD-deficient mice: FADD is required for early T cell development","volume":"98","author":"Kabra","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imlet.2026.107178_bib0024","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ajhg.2010.10.028","article-title":"Whole-exome-sequencing-based discovery of human FADD deficiency","volume":"87","author":"Bolze","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.imlet.2026.107178_bib0025","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/bjh.18871","article-title":"Expanding the clinical phenotype of FADD deficiency with a novel mutation and its role in Fas-mediated apoptotic pathway","volume":"202","author":"Setia","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.imlet.2026.107178_bib0026","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1111\/epi.18008","article-title":"FADD gene pathogenic variants causing recurrent febrile infection-related epilepsy syndrome: case report and literature review","volume":"65","author":"Giovannini","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.imlet.2026.107178_bib0027","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1182\/blood-2014-02-553834","article-title":"Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients","volume":"124","author":"Neven","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2026.107178_bib0028","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaci.2023.09.028","article-title":"Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome","volume":"153","author":"Pell\u00e9","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2026.107178_bib0029","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jaci.2023.11.006","article-title":"Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing","volume":"153","author":"Rensing-Ehl","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2026.107178_bib0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature01063","article-title":"Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency","volume":"419","author":"Chun","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2026.107178_bib0031","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s10875-015-0150-8","article-title":"Caspase-8 Deficiency presenting as late-onset multi-organ lymphocytic infiltration with granulomas in two adult siblings","volume":"35","author":"Niemela","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2026.107178_bib0032","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/j.gastro.2018.09.041","article-title":"Intestinal inflammation and dysregulated immunity in patients with inherited Caspase-8 deficiency","volume":"156","author":"Lehle","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imlet.2026.107178_bib0033","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-8674(00)80605-4","article-title":"Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II","volume":"98","author":"Wang","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2026.107178_bib0034","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41419-024-06679-6","article-title":"Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome","volume":"15","author":"Consonni","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.imlet.2026.107178_bib0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.celrep.2017.04.010","article-title":"Caspase-10 negatively regulates Caspase-8-mediated cell death, switching the response to CD95L in favor of NF-kappaB activation and cell survival","volume":"19","author":"Horn","year":"2017","journal-title":"Cell Rep."},{"issue":"e20192191","key":"10.1016\/j.imlet.2026.107178_bib0036","article-title":"A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS","volume":"218","author":"Maccari","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2026.107178_bib0037","doi-asserted-by":"crossref","first-page":"eadj5948","DOI":"10.1126\/sciimmunol.adj5948","article-title":"Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells","volume":"9","author":"Staniek","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.imlet.2026.107178_bib0038","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.07595.x","article-title":"Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome","volume":"145","author":"Teachey","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.imlet.2026.107178_bib0039","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","article-title":"Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial","volume":"127","author":"Bride","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2026.107178_bib0040","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.3324\/haematol.2016.153411","article-title":"Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome","volume":"102","author":"Klemann","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.imlet.2026.107178_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2025.100808","article-title":"Whole exome sequencing in children with autoimmune hepatitis identified mutations in genes involved in the mTORC1 signaling pathway","volume":"5","author":"Gaigne","year":"2026","journal-title":"Gastro Hep Adv."},{"key":"10.1016\/j.imlet.2026.107178_bib0042","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaci.2023.11.004","article-title":"Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): a proposed approach to redefining ALPS and other lymphoproliferative immune disorders","volume":"153","author":"Magerus","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2026.107178_bib0043","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.imlet.2026.107178_bib0044","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2026.107178_bib0045","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","article-title":"Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity","volume":"90","author":"Lopez-Herrera","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.imlet.2026.107178_bib0046","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.imlet.2026.107178_bib0047","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2026.107178_bib0048","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2026.107178_bib0049","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2023.06.015","article-title":"Activated phosphoinositide 3-kinase \u03b4 syndrome: update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity","volume":"152","author":"Maccari","year":"2023","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:37:25Z","timestamp":1780515445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247826000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":49,"alternative-id":["S0165247826000519"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107178","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1995\u20132025: A long journey in the ALPS","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"107178"}}